Table I.
Demographic data
| Patient group | Non‐psychotic individuals with AVH | Healthy control group | |
|---|---|---|---|
| N = 35 | N = 35 | N = 36 | |
| Male/female | 14/21 | 13/22 | 14/22 |
| Age (y) | 39.6(13.3) | 42.1 (14.6) | 41.39 (13.3) |
| Range (y) | 18–61 | 19–66 | 21–66 |
| Handedness (r/l) | 30/5 | 30/5 | 31/5 |
| Age of onset AVH (y) | 26.6 (14.1) | 14.0 (11.4) | |
| AVH Duration (y) | 12.5 (12.5) | 27.6 (16.1) | |
| PANSS total scores | 58.8 (13.3) | ||
| PANSS positive scores | 1.9 (3.9) | ||
| PANSS negative scores | 15.0 (5.4) | ||
| PANSS general scores | 28.9 (7.0) | ||
| A‐typical antipsychotic medication | 22 | ||
| Classic antipsychotic medication | 8 | ||
| No antipsychotic medication | 5 | ||
| GAF | 81.9 (8.9) | 87.2 (5.9) | |
| SPQ | 28.7 (13.9) | 9.1 (6.8) | |
| Frequency of AVH | 5.5 (0.8) | 3.8 (1.1) | |
| Emotional valence of AVH | 9 (2.5) | 2.1 (3) | |
| Distress due AVH | 3.2 (1.9) | 0.7 (1.5) | |
| Control on AVH | 3.2 (1) | 1.8 (1.5) | |
| Education level (CASH) | 6.1 (1.3) | 6 (2.1) |